Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials

Journal of the American Academy of Dermatology- United States

doi 10.1016/j.jaad.2018.03.040

Full Text

Abstract

Available in

Date

August 1, 2018

Authors

Publisher

Elsevier BV

Related search

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

SKIN The Journal of Cutaneous Medicine

2019

English

Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study

British Journal of Dermatology

Dermatology

Medicine

2019

English

Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis

Biopharmaceutics and Drug Disposition

Medicine

Pharmacology

Pharmaceutical Science

2018

English

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

English

Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis

British Journal of Dermatology

Dermatology

Medicine

2018

English

Safety and Efficacy of Guselkumab in Japanese Patients With Moderate-To-Severe Plaque Psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study

British Journal of Dermatology

Dermatology

Medicine

2018

English

Efficacy and Safety of Continuous Every 2-Week Dosing of Ixekizumab Over 52 Weeks in Patients With Moderate-To-Severe Plaque Psoriasis in a Randomized Phase 3 Trial (IXORA-P)

British Journal of Dermatology

Dermatology

Medicine

2018

English

A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis

English

Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis

Archives of Dermatology

2004

English

Amanote Research

Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials

Journal of the American Academy of Dermatology- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study

Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis

Safety and Efficacy of Guselkumab in Japanese Patients With Moderate-To-Severe Plaque Psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study

Efficacy and Safety of Continuous Every 2-Week Dosing of Ixekizumab Over 52 Weeks in Patients With Moderate-To-Severe Plaque Psoriasis in a Randomized Phase 3 Trial (IXORA-P)

A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis

Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis